13F HOLDINGS REPORT
Opaleye Management Inc.
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0001493152-24-045811
Total Value
$599.6M
Positions
44
Other Managers
0
Confidential Omitted
No
Holdings (44)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | HARROW HEALTH INC | HROW | 3,990,000 | $179.4M | 29.92% |
| 2 | TG THERAPEUTICS INC | TGTX | 2,280,000 | $53.3M | 8.89% |
| 3 | OCULAR THERAPEUTIX INC | OCUL | 5,025,000 | $43.7M | 7.29% |
| 4 | ARVINAS INC | ARVN | 1,255,000 | $30.9M | 5.16% |
| 5 | CODEXIS INC | CDXS | 8,770,000 | $27.0M | 4.51% |
| 6 | RHYTHM PHARMACEUTICALS INC | RYTM | 500,000 | $26.2M | 4.37% |
| 7 | KEROS THERAPEUTICS INC | KROS | 395,276 | $23.0M | 3.83% |
| 8 | IMMUNOME INC | IMNM | 1,237,500 | $18.1M | 3.02% |
| 9 | LIQUIDIA CORPORATION | LQDA | 1,698,142 | $17.0M | 2.83% |
| 10 | ETON PHARMACEUTICALS INC | ETON | 2,780,000 | $16.7M | 2.78% |
| 11 | EDGEWISE THERAPEUTICS INC | EWTX | 522,500 | $13.9M | 2.33% |
| 12 | CARGO THERAPEUTICS INC | 14179K101 | 541,437 | $11.8M | 1.97% |
| 13 | APPLIED THERAPEUTICS INC' | 03828A101 | 1,320,000 | $11.2M | 1.87% |
| 14 | VAXCYTE INC | PCVX | 85,000 | $9.7M | 1.62% |
| 15 | NURIX THERAPEUTICS INC | NRIX | 420,000 | $9.4M | 1.57% |
| 16 | ACELYRIN INC | 00445A100 | 1,893,660 | $9.3M | 1.56% |
| 17 | TREVI THERAPEUTICS INC | TRVI | 2,567,990 | $8.6M | 1.43% |
| 18 | BIODESIX INC | BDSX | 3,815,000 | $7.0M | 1.16% |
| 19 | GINKGO BIOWORKS HOLDINGS | DNABW | 820,202 | $6.7M | 1.11% |
| 20 | JASPER THERAPEUTICS INC | JSPRW | 353,500 | $6.6M | 1.11% |
| 21 | XOMA CORP DEL | XOMAP | 250,000 | $6.6M | 1.10% |
| 22 | NUVALENT INC | NUVL | 64,000 | $6.5M | 1.09% |
| 23 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 335,000 | $5.6M | 0.93% |
| 24 | UROGEN PHARMA LTD | URGN | 404,100 | $5.1M | 0.86% |
| 25 | PROTAGONIST THERAPEUTICS INC | PTGX | 105,000 | $4.7M | 0.79% |
| 26 | GOSSAMER BIO INC | GOSS | 8,000,000 | $4.2M | 0.70% |
| 27 | CYTOKINETICS INC | CYTK | 75,300 | $4.0M | 0.66% |
| 28 | KARYOPHARM THERAPEUTICS INC | KPTI | 6,000,000 | $4.0M | 0.66% |
| 29 | GOSSAMER BIO INC | GOSS | 3,665,010 | $3.7M | 0.62% |
| 30 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 967,000 | $3.6M | 0.59% |
| 31 | PROTARA THERAPEUTICS INC | TARA | 1,681,154 | $3.1M | 0.51% |
| 32 | REZOLUTE INC | RZLT | 466,563 | $2.3M | 0.38% |
| 33 | CATALYST PHARMACEUTICALS INC | CPRX | 112,500 | $2.2M | 0.37% |
| 34 | ABCELLERA BIOLOGICS INC | ABCL | 800,000 | $2.1M | 0.35% |
| 35 | LYELL IMMUNOPHARMA INC | LYEL | 1,395,000 | $1.9M | 0.32% |
| 36 | ALLAKOS INC | 01671P100 | 2,407,600 | $1.6M | 0.26% |
| 37 | RELMADA THERAPEUTICS INC | RLMD | 480,000 | $1.6M | 0.26% |
| 38 | PEPGEN INC | PEPG | 179,200 | $1.5M | 0.26% |
| 39 | REVANCE THERAPEUTICS INC | 761330109 | 275,000 | $1.4M | 0.24% |
| 40 | SYROS PHARMACEUTICALS INC | 87184Q206 | 654,943 | $1.4M | 0.23% |
| 41 | AEROVATE THERAPEUTICS INC | 008064107 | 440,000 | $919,600 | 0.15% |
| 42 | REGULUS THERAPEUTICS INC | 75915K309 | 535,000 | $839,950 | 0.14% |
| 43 | IBIO INC | IBIO | 375,000 | $832,500 | 0.14% |
| 44 | ADAGIO MED HLDGS INC | 00534B100 | 110,571 | $285,273 | 0.05% |